These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11152496)

  • 1. Detection of diverse hepatitis C virus (HCV)-specific cytotoxic T lymphocytes in peripheral blood of infected persons by screening for responses to all translated proteins of HCV.
    Wong DK; Dudley DD; Dohrenwend PB; Lauer GM; Chung RT; Thomas DL; Walker BD
    J Virol; 2001 Feb; 75(3):1229-35. PubMed ID: 11152496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of the intrahepatic cytotoxic T lymphocyte response in chronic hepatitis C virus infection.
    Koziel MJ; Walker BD
    Springer Semin Immunopathol; 1997; 19(1):69-83. PubMed ID: 9266632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection.
    Wong DK; Dudley DD; Afdhal NH; Dienstag J; Rice CM; Wang L; Houghton M; Walker BD; Koziel MJ
    J Immunol; 1998 Feb; 160(3):1479-88. PubMed ID: 9570570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C.
    Nelson DR; Marousis CG; Davis GL; Rice CM; Wong J; Houghton M; Lau JY
    J Immunol; 1997 Feb; 158(3):1473-81. PubMed ID: 9013994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals.
    Vertuani S; Bazzaro M; Gualandi G; Micheletti F; Marastoni M; Fortini C; Canella A; Marino M; Tomatis R; Traniello S; Gavioli R
    Eur J Immunol; 2002 Jan; 32(1):144-54. PubMed ID: 11754355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens.
    Urbani S; Uggeri J; Matsuura Y; Miyamura T; Penna A; Boni C; Ferrari C
    Hepatology; 2001 Jun; 33(6):1533-43. PubMed ID: 11391544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of humoral and cell-mediated immune responses directed against hepatitis C virus F protein in subjects co-infected with hepatitis C virus and HIV-1.
    Troesch M; Jalbert E; Canobio S; Boulassel MR; Routy JP; Bernard NF; Bruneau J; Lapointe N; Boucher M; Soudeyns H
    AIDS; 2005 May; 19(8):775-84. PubMed ID: 15867491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DCs pulsed with novel HLA-A2-restricted CTL epitopes against hepatitis C virus induced a broadly reactive anti-HCV-specific T lymphocyte response.
    Guo Z; Zhang H; Rao H; Jiang D; Cong X; Feng B; Wang J; Wei L; Chen H
    PLoS One; 2012; 7(6):e38390. PubMed ID: 22701633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV.
    Koziel MJ; Dudley D; Afdhal N; Choo QL; Houghton M; Ralston R; Walker BD
    J Virol; 1993 Dec; 67(12):7522-32. PubMed ID: 7693974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus-specific CTL responses in PBMC from chimpanzees with chronic hepatitis C: determination of CTL and CTL precursor frequencies using a recombinant canarypox virus (ALVAC).
    Cohard M; Liu Q; Perkus M; Gordon E; Brotman B; Prince AM
    J Immunol Methods; 1998 May; 214(1-2):121-9. PubMed ID: 9692864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.
    Chang KM; Gruener NH; Southwood S; Sidney J; Pape GR; Chisari FV; Sette A
    J Immunol; 1999 Jan; 162(2):1156-64. PubMed ID: 9916747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C.
    Erickson AL; Houghton M; Choo QL; Weiner AJ; Ralston R; Muchmore E; Walker CM
    J Immunol; 1993 Oct; 151(8):4189-99. PubMed ID: 7691940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-A2-restricted cytotoxic T lymphocyte activity during interferon beta therapy in patients with chronic hepatitis C.
    Ohira H; Iwasaki M; Takiguchi J; Rai T; Shishido S; Abe K; Takeda J; Tojo J; Sato Y; Kasukawa R
    Fukushima J Med Sci; 2002 Dec; 48(2):75-83. PubMed ID: 12680611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infection.
    Freeman AJ; Pan Y; Harvey CE; Post JJ; Law MG; White PA; Rawlinson WD; Lloyd AR; Marinos G; Ffrench RA
    J Hepatol; 2003 Mar; 38(3):349-56. PubMed ID: 12586302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inefficient recognition of autologous viral sequences by intrahepatic hepatitis C virus-specific cytotoxic T lymphocytes in chronically infected subjects.
    Giuggio VM; Bonkovsky HL; Smith J; Rothman AL
    Virology; 1998 Nov; 251(1):132-40. PubMed ID: 9813209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus-specific cytolytic T lymphocyte and T helper cell responses in seronegative persons.
    Koziel MJ; Wong DK; Dudley D; Houghton M; Walker BD
    J Infect Dis; 1997 Oct; 176(4):859-66. PubMed ID: 9333142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis.
    Koziel MJ; Dudley D; Wong JT; Dienstag J; Houghton M; Ralston R; Walker BD
    J Immunol; 1992 Nov; 149(10):3339-44. PubMed ID: 1385523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of effector CD8+ T cells in hepatitis C virus-exposed healthy seronegative donors.
    Scognamiglio P; Accapezzato D; Casciaro MA; Cacciani A; Artini M; Bruno G; Chircu ML; Sidney J; Southwood S; Abrignani S; Sette A; Barnaba V
    J Immunol; 1999 Jun; 162(11):6681-9. PubMed ID: 10352286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of a cytotoxic T cell epitope of hepatitis C virus presented by HLA-B*3501 in acute hepatitis.
    Ibe M; Sakaguchi T; Tanaka K; Saito S; Yokota S; Tanaka T; Shimotohno K; Chujoh Y; Shiratori Y; Omata M; Miwa K; Takiguchi M
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1735-44. PubMed ID: 9680137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective induction of type 1 cytotoxic T cell responses in mice with DNA vaccine encoding two hepatitis C virus cytotoxic T lymphocyte epitopes.
    Shi L; Liu S; Fan GX; Sheng L; Ren HX; Yuan YK
    Viral Immunol; 2006; 19(4):702-11. PubMed ID: 17201665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.